Protagenic Therapeutics, Inc.

1.19 USD
+0.21 (+21.43%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Protagenic Therapeutics, Inc. stock is up 26.6% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 34.62% of the previous 27 February’s closed higher than January.

About Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc. engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide.